BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36012885)

  • 1. First Experience and Prospective Evaluation on Feasibility and Acute Toxicity of Online Adaptive Radiotherapy of the Prostate Bed as Salvage Treatment in Patients with Biochemically Recurrent Prostate Cancer on a 1.5T MR-Linac.
    Wegener D; Thome A; Paulsen F; Gani C; Boldt J; Butzer S; Thorwarth D; Moennich D; Nachbar M; Müller AC; Zips D; Boeke S
    J Clin Med; 2022 Aug; 11(16):. PubMed ID: 36012885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Online Adaptive MR-Guided Ultrahypofractionated Radiotherapy of Prostate Cancer on a 1.5 T MR-Linac: Clinical Experience and Prospective Evaluation.
    Potkrajcic V; Gani C; Fischer SG; Boeke S; Niyazi M; Thorwarth D; Voigt O; Schneider M; Mönnich D; Kübler S; Boldt J; Hoffmann E; Paulsen F; Mueller AC; Wegener D
    Curr Oncol; 2024 May; 31(5):2679-2688. PubMed ID: 38785484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High grade glioma radiation therapy on a high field 1.5 Tesla MR-Linac - workflow and initial experience with daily adapt-to-position (ATP) MR guidance: A first report.
    Tseng CL; Chen H; Stewart J; Lau AZ; Chan RW; Lawrence LSP; Myrehaug S; Soliman H; Detsky J; Lim-Fat MJ; Lipsman N; Das S; Heyn C; Maralani PJ; Binda S; Perry J; Keller B; Stanisz GJ; Ruschin M; Sahgal A
    Front Oncol; 2022; 12():1060098. PubMed ID: 36518316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance guided adaptive post prostatectomy radiotherapy: Accumulated dose comparison of different workflows.
    Hassan SP; de Leon J; Batumalai V; Moutrie Z; Hogan L; Ge Y; Stricker P; Jameson MG
    J Appl Clin Med Phys; 2024 Apr; 25(4):e14253. PubMed ID: 38394627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early experience with MR-guided adaptive radiotherapy using a 1.5 T MR-Linac: First 6 months of operation using adapt to shape workflow.
    de Leon J; Crawford D; Moutrie Z; Alvares S; Hogan L; Pagulayan C; Jelen U; Loo C; Aylward JD; Condon K; Dunkerley N; Heinke MY; Sampaio S; Simon K; Twentyman T; Jameson MG
    J Med Imaging Radiat Oncol; 2022 Feb; 66(1):138-145. PubMed ID: 34643065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Radiographers at the Helm: Moving Towards Radiographer-Led MR-Guided Radiotherapy.
    Hales RB; Rodgers J; Whiteside L; McDaid L; Berresford J; Budgell G; Choudhury A; Eccles CL
    J Med Imaging Radiat Sci; 2020 Sep; 51(3):364-372. PubMed ID: 32600981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Online adaptive radiotherapy for head and neck cancers on the MR linear Accelerator: Introducing a novel modified Adapt-to-Shape approach.
    Gupta A; Dunlop A; Mitchell A; McQuaid D; Nill S; Barnes H; Newbold K; Nutting C; Bhide S; Oelfke U; Harrington KJ; Wong KH
    Clin Transl Radiat Oncol; 2022 Jan; 32():48-51. PubMed ID: 34849412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1.5 T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment.
    Alongi F; Rigo M; Figlia V; Cuccia F; Giaj-Levra N; Nicosia L; Ricchetti F; Sicignano G; De Simone A; Naccarato S; Ruggieri R; Mazzola R
    Radiat Oncol; 2020 Mar; 15(1):69. PubMed ID: 32248826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial Feasibility and Clinical Implementation of Daily MR-Guided Adaptive Head and Neck Cancer Radiation Therapy on a 1.5T MR-Linac System: Prospective R-IDEAL 2a/2b Systematic Clinical Evaluation of Technical Innovation.
    McDonald BA; Vedam S; Yang J; Wang J; Castillo P; Lee B; Sobremonte A; Ahmed S; Ding Y; Mohamed ASR; Balter P; Hughes N; Thorwarth D; Nachbar M; Philippens MEP; Terhaard CHJ; Zips D; Böke S; Awan MJ; Christodouleas J; Fuller CD;
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1606-1618. PubMed ID: 33340604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implementation and feasibility of long-course fractionated MR-guided chemoradiotherapy for patients with esophageal cancer: An R-IDEAL stage 1b/2a evaluation of technical innovation.
    Boekhoff MR; Bouwmans R; Doornaert PAH; Intven MPW; Lagendijk JJW; van Lier ALHMW; Rasing MJA; van de Ven S; Meijer GJ; Mook S
    Clin Transl Radiat Oncol; 2022 May; 34():82-89. PubMed ID: 35372703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4D-MRI driven MR-guided online adaptive radiotherapy for abdominal stereotactic body radiation therapy on a high field MR-Linac: Implementation and initial clinical experience.
    Paulson ES; Ahunbay E; Chen X; Mickevicius NJ; Chen GP; Schultz C; Erickson B; Straza M; Hall WA; Li XA
    Clin Transl Radiat Oncol; 2020 Jul; 23():72-79. PubMed ID: 32490218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal monitoring of Apparent Diffusion Coefficient (ADC) in patients with prostate cancer undergoing MR-guided radiotherapy on an MR-Linac at 1.5 T: a prospective feasibility study.
    Almansour H; Schick F; Nachbar M; Afat S; Fritz V; Thorwarth D; Zips D; Bertram F; Müller AC; Nikolaou K; Othman AE; Wegener D
    Radiol Oncol; 2023 Jun; 57(2):184-190. PubMed ID: 37341194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First clinical experiences with a high field 1.5 T MR linac.
    Bertelsen AS; Schytte T; Møller PK; Mahmood F; Riis HL; Gottlieb KL; Agergaard SN; Dysager L; Hansen O; Gornitzka J; Veldhuizen E; ODwyer DB; Christiansen RL; Nielsen M; Jensen HR; Brink C; Bernchou U
    Acta Oncol; 2019 Oct; 58(10):1352-1357. PubMed ID: 31241387
    [No Abstract]   [Full Text] [Related]  

  • 14. Online adaptive MR-guided radiotherapy for rectal cancer; feasibility of the workflow on a 1.5T MR-linac: clinical implementation and initial experience.
    Intven MPW; de Mol van Otterloo SR; Mook S; Doornaert PAH; de Groot-van Breugel EN; Sikkes GG; Willemsen-Bosman ME; van Zijp HM; Tijssen RHN
    Radiother Oncol; 2021 Jan; 154():172-178. PubMed ID: 32976875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First 500 Fractions Delivered with a Magnetic Resonance-guided Radiotherapy System: Initial Experience.
    Sahin B; Zoto Mustafayev T; Gungor G; Aydin G; Yapici B; Atalar B; Ozyar E
    Cureus; 2019 Dec; 11(12):e6457. PubMed ID: 32025388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of delivered dose in prostate cancer patients treated with ultra-hypofractionated radiotherapy on 1.5-Tesla MR-Linac.
    Gao LR; Tian Y; Wang MS; Xia WL; Qin SR; Song YW; Wang SL; Tang Y; Fang H; Tang Y; Qi SN; Yan LL; Liu YP; Jing H; Chen B; Xing NZ; Li YX; Lu NN
    Front Oncol; 2023; 13():1039901. PubMed ID: 36741014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain stereotactic radiosurgery using MR-guided online adaptive planning for daily setup variation: An end-to-end test.
    Han EY; Wang H; Briere TM; Yeboa DN; Boursianis T; Kalaitzakis G; Pappas E; Castillo P; Yang J
    J Appl Clin Med Phys; 2022 Mar; 23(3):e13518. PubMed ID: 34994101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Tolerability of Online Adaptive High-Field Magnetic Resonance-Guided Radiotherapy.
    Westerhoff JM; Daamen LA; Christodouleas JP; Blezer ELA; Choudhury A; Westley RL; Erickson BA; Fuller CD; Hafeez S; van der Heide UA; Intven MPW; Kirby AM; Lalondrelle S; Minsky BD; Mook S; Nowee ME; Marijnen CAM; Orrling KM; Sahgal A; Schultz CJ; Faivre-Finn C; Tersteeg RJHA; Tree AC; Tseng CL; Schytte T; Silk DM; Eggert D; Luzzara M; van der Voort van Zyp JRN; Verkooijen HM; Hall WA
    JAMA Netw Open; 2024 May; 7(5):e2410819. PubMed ID: 38691356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Implementation and Initial Experience With a 1.5 Tesla MR-Linac for MR-Guided Radiation Therapy for Gynecologic Cancer: An R-IDEAL Stage 1 and 2a First in Humans Feasibility Study of New Technology Implementation.
    Lakomy DS; Yang J; Vedam S; Wang J; Lee B; Sobremonte A; Castillo P; Hughes N; Mohammedsaid M; Jhingran A; Klopp AH; Choi S; Fuller CD; Lin LL
    Pract Radiat Oncol; 2022; 12(4):e296-e305. PubMed ID: 35278717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility study of adaptive radiotherapy for esophageal cancer using artificial intelligence autosegmentation based on MR-Linac.
    Wang H; Liu X; Song Y; Yin P; Zou J; Shi X; Yin Y; Li Z
    Front Oncol; 2023; 13():1172135. PubMed ID: 37361583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.